Association Between the Size and 3D CT-Based Radiomic Features of Breast Cancer Hepatic Metastasis.
Computed tomography
Features
Gray levels
Radiomics
Texture
Tumor size
Journal
Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
03
01
2020
revised:
28
02
2020
accepted:
04
03
2020
pubmed:
19
4
2020
medline:
16
4
2021
entrez:
19
4
2020
Statut:
ppublish
Résumé
To evaluate the effect of the anatomic size on 3D radiomic imaging features of the breast cancer hepatic metastases. CT scans of 81 liver metastases from 54 patients with breast cancer were evaluated. Ten most common 3D radiomic features from the histogram and gray level co-occurrence matrix (GLCM) categories were calculated for the hepatic metastases (HM) and compared to normal liver (NL). The effect of size was evaluated by using linear mixed-effects regression models. The effect of size on different radiomic features was analyzed for both liver lesions and background liver. Three-dimensional radiomic features from GLCM demonstrate an important size dependence. The texture-feature size dependence was found to be different among feature categories and between the HM and NL, thus demonstrating a discriminatory power for the tissue type. Significant difference in the slope was found for GLCM homogeneity (NL slope = 0.004, slope difference 95% confidence interval [CI] 0.06-0.1, p <0.001), contrast (NL slope = 45, slope difference 95% CI 205-305, p <0.001), correlation (NL slope = 0.04, slope difference 95% CI 0.11-0.21, p <0.001), and dissimilarity (NL slope = 0.7, slope difference 95% CI 3.6-5.4, p <0.001). The GLCM energy (NL slope = 0.002, slope difference 95% CI -0.0005 to -0.0003, p <0.007), and entropy (NL slope = 1.49, slope difference 95% CI 0.07-0.52, p <0.009) exhibited size-dependence for both NL and HM, although demonstrating a difference in the slope between themselves. Radiomic features of breast cancer hepatic metastasis exhibited significant correlation with tumor size. This finding demonstrates the complex behavior of imaging features and the need to include feature-specific properties into radiomic models.
Identifiants
pubmed: 32303447
pii: S1076-6332(20)30145-8
doi: 10.1016/j.acra.2020.03.004
pmc: PMC10029938
mid: NIHMS1876630
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e93-e100Subventions
Organisme : NCI NIH HHS
ID : R01 CA196967
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA241532
Pays : United States
Informations de copyright
Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
Références
J Med Imaging (Bellingham). 2015 Oct;2(4):041007
pubmed: 26835491
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Magn Reson Imaging. 2017 Aug;46(2):604-616
pubmed: 28152264
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Eur J Radiol. 2017 Sep;94:140-147
pubmed: 28712700
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
Sci Rep. 2016 Nov 22;6:37241
pubmed: 27872484
Expert Rev Precis Med Drug Dev. 2016;1(2):207-226
pubmed: 28042608
Lancet Oncol. 2018 Sep;19(9):1180-1191
pubmed: 30120041
J Nucl Med. 2015 Jan;56(1):38-44
pubmed: 25500829
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
pubmed: 10655437
Clin Cancer Res. 2013 May 15;19(10):2629-36
pubmed: 23669423
Cancer J. 2009 Sep-Oct;15(5):406-20
pubmed: 19826361
Nat Rev Cancer. 2012 Apr 19;12(5):323-34
pubmed: 22513401
Br J Cancer. 2020 Mar;122(7):929-930
pubmed: 31937924
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
J Clin Oncol. 2007 May 1;25(13):1753-9
pubmed: 17470865
Radiology. 2013 May;267(2):444-53
pubmed: 23382290
Sci Rep. 2017 Aug 11;7(1):7952
pubmed: 28801575
Sci Rep. 2016 Mar 24;6:23428
pubmed: 27009765
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Clin Cancer Res. 2009 Dec 1;15(23):7412-20
pubmed: 19934295
Acad Radiol. 2014 Aug;21(8):950-7
pubmed: 24833565
Sci Rep. 2018 Jul 12;8(1):10545
pubmed: 30002441
Clin Transl Oncol. 2014 Aug;16(8):739-45
pubmed: 24338508
Oncologist. 2014 Apr;19(4):394-402
pubmed: 24652387
PLoS One. 2014 Oct 20;9(10):e110300
pubmed: 25330171